PT-141 Also known as Bremelanotide
PT-141, also known as Bremelanotide, is an innovative peptide hormone treatment shown to be effective for improving sexual function in men and women. PT-141 supports treatment of erectile dysfunction and increased libido in men and improves female sexual arousal disorder in women. PT-141 works directly through the nervous system to increase arousal, desire, and satisfaction with sex. PT-141 peptide induces desire and motivation for sex, increases blood flow to the penis or vagina and clitoris.
About PT-141 (Bremelanotide)
Bremelanotide (PT-141) is a derivative of the peptide hormone, Melanotan II. In initial testing, Melanotan II induced darkening of skin pigment, but additionally caused sexual arousal and spontaneous erections as unexpected side effects in nine out of the ten original male volunteer test subjects. Further testing in animals showed Bremelanotide to induce lordosis (a sexual mating behavior) and subsequently tested for its effect in humans. Although, most of the research has been targeted to women with female sexual dysfunction and
it is effective medication in treating sexual dysfunction in both men (erectile dysfunction or impotence) and women (sexual arousal disorder).